Novel pharmaceutical composition containing at least one Dolastatin 10 derivative

Details for Australian Patent Application No. 2005315912 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Aoki, Yuko; Sawamura, Fumie; Yamazaki, Toshikazu; Miwa, Masanori; Tanimura, Hiromi

Agent Davies Collison Cave

Pub. Number AU-A-2005315912

PCT Pub. Number WO2006/063707

Priority 04106522.8 13.12.04 EP; 05100866.2 08.02.05 EP

Filing date 5 December 2005

Wipo publication date 22 June 2006

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 31/282 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/7068 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/063707 Priority application(s): WO2006/063707

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005315913-Tetracyclic imidazo-benzodiazepines as GABA receptors modulators

2005315902-Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use